| Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods P Karmwar, K Graeser, KC Gordon, CJ Strachan, T Rades International journal of pharmaceutics 417 (1-2), 94-100, 2011 | 178 | 2011 |
| Correlating thermodynamic and kinetic parameters with amorphous stability KA Graeser, JE Patterson, JA Zeitler, KC Gordon, T Rades European journal of pharmaceutical sciences 37 (3-4), 492-498, 2009 | 168 | 2009 |
| Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin KA Graeser, CJ Strachan, JE Patterson, KC Gordon, T Rades Crystal growth and design 8 (1), 128-135, 2008 | 116 | 2008 |
| The role of configurational entropy in amorphous systems KA Graeser, JE Patterson, JA Zeitler, T Rades Pharmaceutics 2 (2), 224-244, 2010 | 108 | 2010 |
| Amorphous drugs and dosage forms H Grohganz, K Löbmann, P Priemel, KT Jensen, K Graeser, C Strachan, ... Journal of Drug Delivery Science and Technology 23 (4), 403-408, 2013 | 83 | 2013 |
| Theoretical considerations in developing amorphous solid dispersions R Laitinen, PA Priemel, S Surwase, K Graeser, CJ Strachan, H Grohganz, ... Amorphous solid dispersions: theory and practice, 35-90, 2014 | 64 | 2014 |
| Investigations on the effect of different cooling rates on the stability of amorphous indomethacin P Karmwar, JP Boetker, KA Graeser, CJ Strachan, J Rantanen, T Rades European journal of pharmaceutical sciences 44 (3), 341-350, 2011 | 63 | 2011 |
| Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin P Karmwar, K Graeser, KC Gordon, CJ Strachan, T Rades European journal of pharmaceutics and biopharmaceutics 80 (2), 459-464, 2012 | 58 | 2012 |
| The ability of two in vitro lipolysis models reflecting the human and rat gastro-intestinal conditions to predict the in vivo performance of SNEDDS dosing regimens SDS Jørgensen, M Al Sawaf, K Graeser, H Mu, A Müllertz, T Rades European Journal of Pharmaceutics and Biopharmaceutics 124, 116-124, 2018 | 48 | 2018 |
| Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin KA Graeser, JE Patterson, T Rades Current drug delivery 6 (4), 374-382, 2009 | 36 | 2009 |
| Measurement of amorphous indomethacin stability with NIR and Raman spectroscopy JY Kao, CM McGoverin, KA Graeser, T Rades, KC Gordon Vibrational Spectroscopy 58, 19-26, 2012 | 19 | 2012 |
| Exploring the utility of the Chasing Principle: influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension SDS Jørgensen, T Rades, H Mu, K Graeser, A Müllertz Acta pharmaceutica sinica B 9 (1), 194-201, 2019 | 18 | 2019 |
| Molecular structure, properties, and states of matter T Rades, KC Gordon, K Graeser Remington: Essentials of Pharmaceutics; Pharmaceutical Press: London, UK …, 2013 | 16 | 2013 |
| Development of stable liquid formulations for oligonucleotides J Poecheim, KA Graeser, J Hoernschemeyer, G Becker, K Storch, M Printz European Journal of Pharmaceutics and Biopharmaceutics 129, 80-87, 2018 | 13 | 2018 |
| Amorphous Solid Dispersions R Laitinen, PA Priemel, S Surwase, K Graeser, CJ Strachan, H Grohganz, ... Advances in Delivery Science and Technology, 35-44, 2014 | 12 | 2014 |
| Physical stability of amorphous drugs: Evaluation of thermodynamic and kinetic parameters KA Graeser, JE Patterson, T Rades Journal of Pharmacy and Pharmacology 60, A-46, 2009 | 10 | 2009 |
| Principles of controlled release Y Perrie, T Rades, K Graeser Drug Delivery: Fundamentals and Applications, 25-46, 2016 | 2 | 2016 |
| Antisense oligonucleotides and their technical suitability to nebulization LL Seidl, R Moog, KA Graeser International Journal of Pharmaceutics 661, 124390, 2024 | | 2024 |
| Salts and crystalline forms of a taar1 agonist KA Graeser, U Schwitter, F Stowasser, FNA Tixeront, R Trussardi US Patent App. 17/946,743, 2023 | | 2023 |
| MOLECULAR STRUCTURE AND PROPERTIES 177 STATES OF MATTER 189 T Rades, KC Gordon, K Graeser Remington-Essentials of Pharmaceutics, 177, 2013 | | 2013 |
